FAST BioMedical’s first-in-class approach to measuring both volume status and kidney function has the potential to revolutionize treatment of heart failure patients. Our innovative technology combines injectable fluorescent markers, a proprietary device with a unique set of algorithms. The system allows you to measure intravascular volume multiple times over a six hour period. Additionally, the technology provides a measured glomerular filtration rate. The technology fits easily into routine clinical workflow and does not require use of radioactive materials or placement of costly and cumbersome sensors.
Having access to a technology that would allow accurate measurement of both blood volume and GFR in heart failure patients could be a tremendous step forward for patient assessment and determining the correct approach to apply therapies.
- Dr. Stefan Anker, Head of Field “Tissue Homeostasis and Cachexia,” Charité University, Berlin, Germany
